A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.
ANIP drugs
ANIP drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 11 $78.71entry
- T+1 · 6mo ago +1.00%α +1.14% · $79.50
- T+5 · 6mo ago +0.80%α +0.89% · $79.34
- T+20 · 6mo ago +3.16%α +3.47% · $81.20
- T+60 · 4mo ago +1.49%α −2.91% · $79.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider sales at ANI Pharmaceuticals, led by CEO Nikhil Lalwani selling $4.27M worth of shares, follows a strong Q1 2026 earnings beat and raised guidance. The total insider selling of ~$5.7M over the cluster window represents about 0.3% of market cap, which is modest but notable given the CEO's participation. The sales are likely liquidity-driven after a significant stock run-up post-earnings, but the cluster's timing and size warrant monitoring for any upcoming negative catalysts.
Key Financial Metrics
Key Facts
- CEO Nikhil Lalwani sold 55,000 shares for $4.27M on May 11, 2026.
- Director Patrick Walsh sold a total of ~14,000 shares for $1.13M over May 11-13.
- Total insider sales in the cluster: ~$5.7M, or ~0.3% of ANIP's $1.8B market cap.
- Q1 2026 revenue was $237.5M (+20.5% YoY), beating consensus of $207.6M.
- GAAP diluted EPS of $1.28 beat consensus of $1.30.
- Company raised full-year 2026 guidance and authorized a $100M buyback.
- Prior 30-day insider activity showed $5.7M in total sales before this cluster.
Financial Impact
Insider sales of ~$5.7M represent 0.3% of market cap, modest but concentrated in CEO and director.
Risk Factors
- CEO selling a large portion of his stake could signal peak valuation or upcoming headwinds.
- Cluster sales may be followed by more insider selling if the stock continues to rally.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ANIP-1778718158958 |
Track record
34 reports on ANIP
4 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +8.88% at T+60 after the Apr 8, 2026 report. 8 of 12 went positive at some point.
Filters
- Nov 18, 20263d ago Insider Cluster Neutral 2/10 Entry $69.13 Now $68.55 −0.84% settles Dec 18
- Nov 16, 20265d ago 144 Neutral 2/10 Entry $69.99 Now $68.55 −2.06% settles Dec 16
- Nov 16, 20266d ago 8-K Neutral 3/10 Entry $70.89 Now $68.55 −3.30% settles Dec 15
- Nov 9, 202612d ago Institutional Cluster Mixed 3/10 Entry $67.79 Now $68.55 +1.12% settles Dec 8
- Nov 5, 202616d ago 8-K Neutral 5/10 Entry $67.41 Now $68.55 +1.69% settles Dec 7
- Nov 5, 202617d ago 8-K Bullish 6/10 No price data
- Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
- Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
- Nov 5, 202617d ago Press Release Bullish 6/10 Entry $69.62 Now $68.55 −1.54% settles Dec 4
- Oct 29, 202623d ago 144 Neutral 2/10 Entry $72.00 Now $68.55 −4.79% settles Nov 30
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers